Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.2.1.1 (
ACS
)
78,556
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Apicomplexan parasites include the causative agents of malaria and toxoplasmosis. Cell-based screens in
Toxoplasma
previously identified a chemical modulator of calcium signaling (
ENH1
) that blocked parasite egress from host cells and exhibited potent antiparasitic activity. To identify the targets of
ENH1
, we adapted thermal proteome profiling to
Toxoplasma
, which revealed calcium-dependent protein kinase 1 (CDPK1) as a target. We confirmed the inhibition of CDPK1 by
ENH1
in vitro and in parasites by comparing alleles sensitive or resistant to
ENH1
. CDPK1 inhibition explained the block in egress; however, the effects of
ENH1
on calcium homeostasis and parasite viability were CDPK1-independent, implicating additional targets. Thermal proteome profiling of lysates from parasites expressing the resistant allele of CDPK1 identified additional candidates associated with the mitochondria and the parasite pellicle-compartments that potentially function in calcium release and homeostasis. Our findings illustrate the promise of thermal profiling to identify druggable targets that modulate calcium signaling in apicomplexan parasites.
ACS
Chem Biol 2020 07 17
PMID:Identifying the Target of an Antiparasitic Compound in
Toxoplasma
Using Thermal Proteome Profiling. 3259 28